Help us fund research to slow, stop or reverse Parkinson’s
BBC News Anchor, Sophie Raworth, chose to run the Virgin Money London Marathon in support of the work of The Cure Parkinson's Trust following her father's Parkinson's diagnosis. Read more
A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease. Read more
The cholesterol-lowering drug Simvastatin is to be trialled as a potential neuroprotective treatment for Parkinson’s. This country-wide trial part-funded by CPT and led by Plymouth University is now underway. Read more
The Cure Parkinson's Trust supported Linked Clinical Trials committee assessed compelling biochemical evidence of specific existing treatments for other conditions, with the potential to be repurposed to treat Parkinson's. Read more
Help us fund research to slow, stop or reverse Parkinson’s.
This research update meeting took place on the 4th April. We would like to thank everyone who came along in support of our work.
If you were not able to join us on the day, all the presentations were recorded and are now available to view.
An independent study part funded by The Cure Parkinson's Trust suggests that the genetic make-up of stem cells, which have been specifically developed for use as clinical therapies, are fit for use in patients.
On Sunday 24th April, CPT's team of dedicated runners hit the streets of London in support of our research. We can't thank them enough for their mammoth efforts over these past months and, of course, that huge feat yesterday!
A research paper recently published in the Journal of Parkinson's Disease discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells. Read more
On Sunday 24th April, CPT's team of dedicated runners hit the streets of London in support of our research. We can't thank them enough for their mammoth efforts over these past months and, of course, that huge feat yesterday! Read more
Researchers at La Trobe University in Australia have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease. Read more
Tim Hart, owner of Hambleton Hall, talks about his life as a hotelier and restauranter at Staverton. Read more
The International Parkinson and Movement Disorder Society (MDS) gathers clinicians, researchers, trainees and industry supporters on an annual basis at its International Congress of Parkinson's Disease and Movement Disorders.
The World Parkinson Congress in Portland USA provides an international forum for dialogue on the latest scientific discoveries, medical practices and caregiver initiatives related to Parkinson’s disease (PD).This conference in open to all members of the Parkinson's community. Read more